Search | SPORTIVO Network

nk99fmi added blog Health
2026-07-25 13:06:16

Breast Cancer Drug Market Expected to Expand with Rising Demand for Precision Oncology Treatments
The Breast Cancer Drug Market is expected to maintain steady growth as the global healthcare industry continues to prioritize long-term treatment strategies for breast cancer, particularly hormone receptor-positive (HR+) and HER2-negative disease. According to Future Market Insights (FMI), the market is projected to grow from USD 11.1 billion in 2026 to USD 12.4 billion by 2036, registering a...

0 Comments 0 Shares 120 Views 0 Reviews

Please log in to like, share and comment!
nk99fmi added blog Health
2026-07-25 13:06:36

Breast Cancer Drug Market Expected to Expand with Rising Demand for Precision Oncology Treatments
The Breast Cancer Drug Market is expected to maintain steady growth as the global healthcare industry continues to prioritize long-term treatment strategies for breast cancer, particularly hormone receptor-positive (HR+) and HER2-negative disease. According to Future Market Insights (FMI), the market is projected to grow from USD 11.1 billion in 2026 to USD 12.4 billion by 2036, registering a...

0 Comments 0 Shares 168 Views 0 Reviews

Please log in to like, share and comment!
rohit001 added blog Literature
2026-06-24 06:25:12

SERD (Selective Estrogen Receptor Degrader) Drug Market Advances with Expanding Breast Cancer Research and Next-Generation Hormone Therapy Innovations
According to the latest report published by Data Bridge Market Research, the SERD (Selective Estrogen Receptor Degrader) Drug Market The global SERD (Selective Estrogen Receptor Degrader) drug market size was valued at USD 2.84 billion in 2025 and is expected to reach USD 8.93 billion by 2033, at a CAGR of 15.40% during the forecast period The persuasive SERD (Selective Estrogen...

0 Comments 0 Shares 394 Views 0 Reviews

Please log in to like, share and comment!
rishika_2003 added blog Health
2026-03-18 05:43:48

Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer Prevention
According to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!